Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and EvaluationBiruk Sintayehu Fanta, Shudong Wang|Molecules|2023Cited by 8